• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Diffuse large B-cell lymphoma on the back of a patient with AIDS: successful treatment by the CD20 monoclonal antibody rituximab.

作者信息

Voigtländer Constanze, Harrer Thomas, Schneider Lothar, Schulze-Koops Hendrik, Niedobitek Gerald, Lüftl Matthias

出版信息

Int J Dermatol. 2005 Nov;44(11):976-8. doi: 10.1111/j.1365-4632.2005.02649.x.

DOI:10.1111/j.1365-4632.2005.02649.x
PMID:16336543
Abstract
摘要

相似文献

1
Diffuse large B-cell lymphoma on the back of a patient with AIDS: successful treatment by the CD20 monoclonal antibody rituximab.一名艾滋病患者背部的弥漫性大B细胞淋巴瘤：通过CD20单克隆抗体利妥昔单抗成功治疗。
Int J Dermatol. 2005 Nov;44(11):976-8. doi: 10.1111/j.1365-4632.2005.02649.x.
2
[Relapse of diffuse large B cell lymphoma to CD20-negative multiple cutaneous tumors immediately after anti-CD20 monoclonal antibody (rituximab) therapy].[弥漫性大B细胞淋巴瘤在抗CD20单克隆抗体（利妥昔单抗）治疗后立即复发为CD20阴性的多发性皮肤肿瘤]
Rinsho Ketsueki. 2004 Oct;45(10):1129-34.
3
Diffuse large B-cell primary gastric lymphoma treated successfully with the CD20 monoclonal antibody (rituximab): a case with severe liver dysfunction due to liver cirrhosis and hepatocellular carcinoma.采用CD20单克隆抗体（利妥昔单抗）成功治疗弥漫性大B细胞原发性胃淋巴瘤：一例因肝硬化和肝细胞癌导致严重肝功能障碍的病例
Oncol Rep. 2005 Jun;13(6):1065-8.
4
Primary effusion lymphoma: successful treatment with highly active antiretroviral therapy and rituximab.原发性渗出性淋巴瘤：高效抗逆转录病毒疗法联合利妥昔单抗治疗成功
Ann Hematol. 2005 Aug;84(8):551-2. doi: 10.1007/s00277-005-1040-6. Epub 2005 Mar 31.
5
[Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].利妥昔单抗联合CHOP方案与单纯CHOP方案治疗初治弥漫性大B细胞淋巴瘤患者的比较
Ai Zheng. 2005 Dec;24(12):1498-502.
6
[Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].含利妥昔单抗的挽救方案对复发或难治性B细胞非霍奇金淋巴瘤的疗效
Ai Zheng. 2006 Apr;25(4):486-9.
7
[Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China--a multi-center randomized trail].中国R-CHOP方案与CHOP方案治疗初治弥漫大B细胞淋巴瘤的比较——一项多中心随机试验
Ai Zheng. 2005 Dec;24(12):1421-6.
8
Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.利妥昔单抗及其在非霍奇金淋巴瘤维持治疗中的作用。
Expert Rev Anticancer Ther. 2007 Mar;7(3):257-73. doi: 10.1586/14737140.7.3.257.
9
Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial.环磷酰胺、阿霉素、长春新碱、泼尼松和利妥昔单抗治疗人类免疫缺陷病毒相关弥漫性大B细胞淋巴瘤患者的安全性和有效性：一项II期试验的结果
Br J Haematol. 2008 Feb;140(4):411-9. doi: 10.1111/j.1365-2141.2007.06943.x. Epub 2007 Dec 19.
10
An imaging-based rapid evaluation method for complement-dependent cytotoxicity discriminated clinical response to rituximab-containing chemotherapy.一种基于成像的补体依赖性细胞毒性快速评估方法可区分含利妥昔单抗化疗的临床反应。
Clin Cancer Res. 2009 May 15;15(10):3624-32. doi: 10.1158/1078-0432.CCR-08-1536. Epub 2009 May 5.